Wow, if I am reading this correctly, this is a huge validation of Miya Precision given that the research team will be using Alcidion’s product in a sort of top-down approach “...to identify priority areas where clinical decision support tools will add value”.
Any other interpretations?
Alcidion to participate in a new $1.5million research project through the Digital Health CRC (DHCRC), page-5
Add ALC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.002(3.33%) |
Mkt cap ! $77.86M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.7¢ | $76.91K | 1.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 335963 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 193750 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.9¢ |
Change
-0.002 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 5.9¢ | 5.7¢ | 677662 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| ALC (ASX) Chart |